Skip to content

ANNESTHESIA

Active Private limited companyfounded 2014active for 12 yearsLangehaagstraat 4, 1000 BrusselsKBO/BCE: BE 0553.867.030

Lifetime

11 annual accounts with figures on one time axis
peak €80,473 (2015)
€77,023▲ 10.4%
lowest -€85,269 (2020)
€18,416▲ 43.3%
peak €37,477 (2016)
-€61,362▲ €18,416
€519,556▼ 6.6%
Board2 names since 2014
1 directorVANHECKE Anne
Documentsfilings and deeds
05-10-202666 days late
2025micro format
Result from €12,854 to €18,416Equity from -€79,778 to -€61,362Cash from €36,187 to €20,602

Key points

from the 2025 annual accounts

Equity

-€61,362
202020212022202320242025

Debts exceed assets in financial year 2025.

Turnover

≈ €170,000 estimated

The micro format states no turnover.

Debts

€519,556 113% of the balance sheet
Suppliers 1%Taxes and wages 0%Other 99%

Of this, €519,284 falls due within a year.

Filings

11 annual accounts 66 days
AprilJune31 JulyOctober201520202025

Latest accounts filed late: after the legal deadline.

Position in the sector

-13.4%

Lower solvency than 95% of companies in human health. Sector median 63.0% · 20,767 companies.

Checked score

54
Fair
Financially stronger than 22% of micro companies in human health (NACE 86)
Probability in this band: 1.5% to 4.2%

Negative equity caps the score at 59.

Bankruptcy probability within 12 months
0.3% Very low
0%0.5%1.5%4%10%≥ 25%

The dashed line is the sector median: < 0.1% across 24,185 companies (NACE 86, micro).

About 3 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Last 24 months 12-2024: 0.3% 01-2025: 0.3%● unchanged vs 12-2024 02-2025: 0.3%● unchanged vs 01-2025 03-2025: 0.4%▲ +0.1 percentage points vs 02-2025 04-2025: 0.4%● unchanged vs 03-2025 05-2025: 0.4%● unchanged vs 04-2025 06-2025: 0.4%● unchanged vs 05-2025 07-2025: 0.4%● unchanged vs 06-2025 08-2025: 0.5%▲ +0.1 percentage points vs 07-2025 09-2025: 0.6%▲ +0.1 percentage points vs 08-2025highest value 10-2025: 0.2%▼ -0.4 percentage points vs 09-2025 11-2025: 0.2%● unchanged vs 10-2025 12-2025: 0.2%● unchanged vs 11-2025 01-2026: 0.2%● unchanged vs 12-2025lowest value 02-2026: 0.2%● unchanged vs 01-2026 03-2026: 0.2%● unchanged vs 02-2026 04-2026: 0.2%● unchanged vs 03-2026 05-2026: 0.2%● unchanged vs 04-2026 06-2026: 0.2%● unchanged vs 05-2026 07-2026: 0.3%▲ +0.1 percentage points vs 06-2026 08-2026: 0.4%▲ +0.1 percentage points vs 07-2026 09-2026: 0.4%● unchanged vs 08-2026 10-2026: 0.3%▼ -0.1 percentage points vs 09-2026 11-2026: 0.3%● unchanged vs 10-2026

Financial strength
Weak

12+4equity -13.4% of total assets
6-3short-term debt 113.3% · cash 4.5%
74+2return on assets 4.0%

Score breakdown

raises risk
Capped at 59: negative equity
Last filed accounts filed 66 days late; 3 of the last 3 accounts late
Negative equity -€61,362
lowers risk
Sector: Human health activities (NACE 86)
Size: total assets €458,194
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 2% of them on solvency, 1% on liquidity, 18% on profitability and 67% on growth.

The bankruptcy probability was computed on 09-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Comparable companies, two years later

In July 2024, 522 companies had the same profile as ANNESTHESIA has now. Each dot stands for 2 companies, two years later.

93.7%
were still trading
1.7%
stopped another way
3.8%
went bankrupt
  • Small
  • 10 to 20 years old
  • negative equity
  • a profit under 5% of the balance sheet

Another 0.8% stopped without a precise date, possibly only after those two years.

The bankruptcy probability of ANNESTHESIA itself is lower: 0.3% within 12 months. It rests on far more data about ANNESTHESIA than the profile alone.

Test of the method

The method was tested on the 497,447 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 522 companies, not a prediction for ANNESTHESIA. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

No credit on open account

Liquidity is insufficient, with a current ratio of 0.08 (0.09 in 2024), below 1. Short-term debt is 113.3% and cash 4.5% of total assets. Equity is negative.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises risk
lowers risk · Sector: Human health activities (NACE 86)
KBO
raises risk · Last filed accounts filed 66 days late; 3 of the last 3 accounts late
NBB · filings
lowers risk · Size: total assets €458,194
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Negative equity -€61,362
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20767 sector peers (2025).
NBB · sector comparison
Position among 20767 sector peers
Solvency
better than 5%
← weakest strongest →
raises risk · 2025 accounts filed 66 days late
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 05-10-2026, 66 days later. Nearly half (47%) of Belgian companies file late; of those that file 1 to 90 days late, 2.0% are now bankrupt, dissolved or in another special legal status, against 1.66% of all filers. A delay like this does not count in the score.
NBB · 10 filings
Deviation from the deadline
2025
66 days late
2024
54 days late
2023
61 days late
2022
92 days late
2021
96 days late
2020
96 days late
2019
242 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 101 days after the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 5 October (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
10-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Board and ownership

VA
Director, since 13-06-2014
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0553867030
Appointment: Kian Dolatabadi (director) General meeting of 11-07-2024 · Gazette deed
Change of role: VANHECKE Anne, from manager to director “L'aide au développement, promotion et diffusion de logiciels médicaux; La création et diffusion de sites…” (deed in French) · Legal-form conversion: from private limited company (pre-2019) to private limited company · Director discharge: VANHECKE Anne · General meeting of 17-03-2020 · Gazette deed
Incorporation published on 26-06-2014 · Gazette deed
All 19 events

Comparable companies

same main activity, similar in size and age
Company
ANNESTHESIA Brussels €458,194 €77,023 -13.4% -
Dokter Alice Fouckova, Endocrinologie Ronse €464,267 €84,827 78.3% -
Andrew CARLIN - Sophie DECHENE Genappe €420,372 €72,697 37.5% -
KINDERARTSENPRAKTIJK OUD en RAYEN Hasselt €471,993 €87,630 24.5% -
Dr Debouck Catherine Linkebeek €443,969 €88,509 91.0% -
MEDIPHILIS Uccle €336,590 €82,646 70.5% -
DOCVANOS Molenbeek-Saint-Jean €590,838 €82,103 95.4% -

These companies have the same main activity as ANNESTHESIA: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €337,000 and €591,000, founded between 2011 and 2015.

Official details

Source: KBO
Status
Active since 17-06-2014Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.313.745.7501000 Brussels, since 13-06-2014
Financial year end
31 December
Peppol
Reachable since 09-04-2026
Company details

Annual accounts 2025

€458,194▼ 3.8%
Filing
Filed on 05-10-2026
Financials

Insights on ANNESTHESIA

ANNESTHESIA files the micro format. That format states no turnover. The gross margin fell from €80,473 in 2015 to €77,023 in 2025.

The balance sheet grew most in 2024 through fixed assets.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ANNESTHESIA

What is the company number of ANNESTHESIA?
The company number of ANNESTHESIA is 0553.867.030. The VAT number is the same number with BE in front: BE 0553.867.030.
Where is ANNESTHESIA based?
The registered office is at Langehaagstraat 4, 1000 Brussels.Company details
What does ANNESTHESIA do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ANNESTHESIA?
ANNESTHESIA is a private limited company (BV).
When was ANNESTHESIA founded?
ANNESTHESIA was founded on 17-06-2014.
Is ANNESTHESIA still active?
Yes, ANNESTHESIA is an active enterprise in the KBO register.
What is the turnover of ANNESTHESIA?
The turnover in financial year 2025 is ≈ €170,000. This figure is estimated from the gross margin of €77,023 and 32 comparable companies (NACE 862). It probably lies between €130,000 and €220,000.Financials
Is ANNESTHESIA profitable?
In financial year 2025, ANNESTHESIA made a profit of €18,416.
Where can I find the annual accounts of ANNESTHESIA?
ANNESTHESIA filed 11 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ANNESTHESIA due?
ANNESTHESIA must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.